<DOC>
	<DOCNO>NCT02386917</DOCNO>
	<brief_summary>Drug bioavailability disposition vary accord body weight weight loss bariatric surgery . This study evaluate impact body weight weight loss pharmacokinetics various probe drug , compare effect three group patient receive either gall bladder operation , gastric bypass low calorie diet .</brief_summary>
	<brief_title>Impact Body Weight Weight Loss Drug Bioavailability , Cardiovascular Risk Factors Metabolic Biomarkers</brief_title>
	<detailed_description>This study aim 1. investigate relationship body composition liver/intestine activity expression protein ( drug metabolize enzyme , transporter regulatory factor ) important drug bioavailability disposition range normal morbid obesity ( combine gastric bypass cholecystectomy group ) baseline . 2. compare short-term ( 6-week ) long-term ( 2 year ) effect gastric bypass ( GBP ) low calorie diet ( VLCD ) ( match weight loss ) bioavailability pharmacokinetics probe drug ( caffeine , omeprazole , digoxin , midazolam , rosuvastatin , losartan ) biomarkers ( adjoin protein expression ) cytochrome P450 ( CYP ) 1A2 , CYP2C9 , CYP2C19 , CYP3A , P-glycoprotein ( gp ) organic anion-transporting polypeptide ( OATP ) 1B1 . 3. compare 3 study group ( GBP , VLCD cholecystectomy ) baseline respect body composition , cardiovascular risk factor metabolic biomarkers . 4. compare short-term ( 6-week ) change glucose metabolism , blood pressure , blood lipid body composition match weight loss long-term effect ( 2 year ) body composition , cardiovascular risk factor metabolic biomarkers , GBP VLCD group .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<criteria>1 . Patients schedule GBP surgery VLCD intervention obesity well patient schedule cholecystectomy . 2 . BMI â‰¥ 18.5 kg/m2 3 . Able willing donate biopsy ( specify protocol ) GBP VLCD patient also willing perform followup 24 hour PKinvestigations assessment require clinical study protocol 4 . Stable body weight ( &lt; 5 kg self report weight change ) last 3 month inclusion . 5 . Signed informed consent . Concomitant treatment drug ( accord available literature , appendix 3 ) and/or factor may influence cocktail drug pharmacokinetics grapefruit juice , Seville oranges , Pomelo juice , St. Johns wort , tobacco coffee/tea close approximation investigation . Bradyarrhythmia , WolffParkinsonWhite ( WPW ) syndrome , atrioventricular block 23 . Electrolyte disturbance ( particularly hypokalemia hypomagnesemia ) . Renal impairment : eGFR &lt; 30 mL/min . Blood donation last 4 month . Previous bariatric upper gastrointestinal surgery . Diabetic patient treat glitazones , insulin sulfonylurea . Pregnancy ( check HCG urine screening ) breastfeeding mother . Known hypersensitivity ( include allergy ) drug include cocktail and/or local anesthesia . Anticoagulants associate risk combination biopsy . Noncompliance regard visit and/or diet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>